主页文献库搜索
Clinical outcomes and molecular profile of differentiated thyroid cancers wit...

Sabra(M M),Dominguez(J M),Grewal(R K),Lars... J Clin Endocrinol Metab 2013-07-05

...PIK3CA mutations were found in 42, 23, 10, and 2% of tumors, respectively, and the remaining 23% were wild type. None of...

Landscape of somatic single-nucleotide and copy-number mutations in uterine s...

Zhao(Siming),Choi(Murim),Overton(John D),B... Proc Natl Acad Sci U S A 2013-04-26

...PIK3CA, ERBB2 (an upstream activator of PIK3CA), and CCNE1 (a target of FBXW7-mediated ubiquitination). These findings i...

Energy deprivation by silibinin in colorectal cancer cells: a double-edged sw...

Raina(Komal),Agarwal(Chapla),Wadhwa(Ritamb... Autophagy 2013-11-22

...PIK3CA-AKT-MTOR but activated MAP2K1/2-MAPK1/3 pathways for its biological effects. Corroborating these effects, endopla...

Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencin...

Ang(Daphne),O'Gara(Rebecca),Schilling(Amy)... J Mol Diagn 2013-12-04

...PIK3CA. We tested 60 FFPE breast DNA samples with known PIK3CA mutation status (48 cases had one or more PIK3CA mutation...

High phospho-Stathmin(Serine38) expression identifies aggressive endometrial ...

Wik(Elisabeth),Birkeland(Even),Trovik(Jone... Clin Cancer Res 2013-11-12

...PIK3CA copy number (FISH) and a PI3K activation score (all P < 0.05).,High pStathmin(S38) is a novel biomarker of increa...

Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BE...

Yang(Fen),Qian(Xiao-Jun),Qin(Wei),Deng(Ron... PLoS One 2013-09-11

...PIK3CA mutation, compared to cells with wild-type PIK3CA. Furthermore, exposure of NPC cells to NVP-BEZ235 resulted in G...

PIK3CA mutation is associated with poor survival among patients with metastat...

Wu(Shuangjie),Gan(Yu),Wang(Xinhai),Liu(Jun... J Cancer Res Clin Oncol 2013-06-21

PIK3CA mutation appears to predict a lack of response to anti-EGFR monoclonal antibody (mAb) treatment in patients with ...

Molecular profiling of cholangiocarcinoma shows potential for targeted therap...

Voss(Jesse S),Holtegaard(Leonard M),Kerr(S... Hum Pathol 2013-08-20

...PIK3CA (n = 5), MET (n = 4), EGFR (n = 1), BRAF (n = 2), and NRAS (n = 1). Mutations were identified in 7 (26%) of 27 ex...

Patterns of DNA mutations and ALK rearrangement in resected node negative lun...

Yip(Po Yee),Yu(Bing),Cooper(Wendy A),Selin... J Thorac Oncol 2013-09-12

...PIK3CA, ALK, PDGFRA, AKT1, BRAF, FGFR1, and HRAS mutations were detected in tumors from 77 (37.7%), 29 (14.2%), 9 (4.4%)...

Utilization of quantitative in vivo pharmacology approaches to assess combina...

Bradshaw-Pierce(Erica L),Pitts(Todd M),Kul... PLoS One 2013-09-10

...PIK3CA mutant HT29 tumor xenografts, which had an additive effect, than the KRAS/PIK3CA mutant HCT116 tumor xenografts, ...

上一页 200 201 202 203 204 205 206 207 208 下一页 204 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com